EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Välk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Leiss L, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PØ, Winkler F, Ritter CA, Niclou SP, Watts C, Bjerkvig R, Miletic H.
Eskilsson E, et al. Among authors: keunen o.
Neuro Oncol. 2016 Dec;18(12):1644-1655. doi: 10.1093/neuonc/now113. Epub 2016 Jun 10.
Neuro Oncol. 2016.
PMID: 27286795
Free PMC article.